Premium
The neuronal SAPK/JNK pathway is altered in a murine model of hyperhomocysteinemia
Author(s) -
Robert Karine,
SantiardBaron Dominique,
Chassé JeanFrancois,
Paly Evelyne,
Aupetit Joelle,
Kamoun Pierre,
London Jacqueline,
Janel Nathalie
Publication year - 2004
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1046/j.1471-4159.2003.02297.x
Subject(s) - hyperhomocysteinemia , cystathionine beta synthase , homocysteine , biology , gene , hippocampal formation , microbiology and biotechnology , endocrinology , medicine , genetics , methionine , amino acid
Deficiency in cystathionine beta synthase (CBS) leads to high plasma homocysteine concentrations and causes hyperhomocysteinemia, a common risk factor for vascular disease, stroke and possibly neurodegenerative diseases. Various neuronal diseases have been associated with hyperhomocysteinemia, but the molecular mechanisms of homocysteine toxicity are unknown. We investigated the pathways involved in the pathological process, by analyzing differential gene expression in neuronal tissues. We used a combination of differential display and cDNA arrays to identify genes differentially expressed during hyperhomocysteinemia in brain of CBS‐deficient mice. In this murine model of hyperhomocysteinemia, both plasma and brain homocysteine concentrations were high. Several genes were found to be differentially expressed in the brains of CBS‐deficient mice, and the identities of some of these genes suggested that the SAPK/JNK pathway was altered in the brains of CBS‐deficient mice. We therefore investigated the activation of proteins involved in the SAPK/JNK cascade. JNK and c‐Jun were activated in the hippocampal neurones of CBS‐deficient mice, suggesting that the SAPK/JNK pathway may play an important role in the development of neuronal defects associated with hyperhomocysteinemia.